Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Olaszország
28 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in OlaszországBexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- Where
- Alessandria, Bologna, Candiolo, Milan
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Faron Pharmaceuticals Ltd
See details and how to joinNCT07672769 · EU 2026-526706-33-00 - 1. fázisNot yet taking people in OlaszországBioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDS
- Where
- Bologna, Ravenna
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07929740 · EU 2025-524332-19-00 - 3. fázisTaking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Ancona, Candiolo, Florence, Milan, Pavia, Reggio Calabria, Rome, Rozzano, Turin
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00 - 3. fázisTaking peopleA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Bologna, Candiolo, Florence, Milan, Naples, Novara, Padova, Pavia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - 1. fázisNot yet taking people in OlaszországFirst-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
- Where
- Bergamo, Pisa, Rozzano
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Genmab
See details and how to joinNCT07384715 · EU 2025-523101-15-00 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Bologna, Ravenna
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 2. fázisFut, nem toborozA Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
- Where
- Milan, Padova, Reggio Emilia, Roma
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Swedish Orphan Biovitrum
See details and how to joinNCT06782373 · EU 2024-516347-41-00 - 3. fázisTaking peopleLisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- Where
- Candiolo, Ferrara, Florence, Meldola, Milan, Novara, Ravenna, Rome, Rozzano, Torino, Varese
- Életkor
- 18 év and over
- People
- 490 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00 - 2/3. fázisTaking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Bologna, Florence, Milan, Novara, Ravenna, Rome, Turin
- Életkor
- 18 év and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - 4. fázisNot yet taking people in OlaszországRegistry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residual disease.
- Where
- Bologna, Busto Arsizio, Milan, Modena, Novara, Padova, Perugia, Pescara, Ravenna, Rimini, Rome
- Életkor
- 18 év and over
- People
- 365 worldwide
- Run by
- Medizinische Hochschule Hannover
See details and how to join2024-512503-39-00 - 1/2. fázisTaking peopleStudy Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
- Where
- Candiolo, Firenze
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Groupe Francophone des Myelodysplasies
See details and how to joinNCT05181735 · EU 2024-515354-24-00 - 2. fázisNot yet taking people in OlaszországRVU120 Rollover Study
- Where
- Bari
- Életkor
- 18 év and over
- People
- 14 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06987058 · EU 2025-521673-14-00 - 2. fázisLeállítva(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Bologna, Florence, Salerno, Verona
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 1/2. fázisTaking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Bologna, Meldola, Milan
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - No phaseTaking peopleItalian Network MDS Registry
- Where
- Alessandria, Ancona, Asti, Bari, Bologna, Cagliari, Candiolo, Chieri, Florence, Genova, Orbassano, Padova, Parma, Perugia, Pesaro, Rionero in Vulture, Torino, Tricase
- Életkor
- 18 év to 106 év
- People
- 10 000
- Run by
- Fondazione Italiana Sindromi Mielodisplastiche-ETS
See details and how to joinNCT02808858 - 3. fázisTaking peopleIvosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- Where
- Ancona, Bologna, Florence, Pavia, Rome, Rozzano, Turin
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT06465953 · EU 2023-510155-37-00 - 2. fázisCsak meghívásosA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Milan
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - 1/2. fázisNot yet taking people in OlaszországA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Bologna, Naples, Padova, Pavia, Rozzano
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - 3. fázisTaking peopleA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Allessandria, Bologna, Brindisi, Cagliari, Ferrara, Florence, Genoa, Lecce, Milan, Modena, Naples, Orbassano, Pavia, Reggio Calabria, Roma, Rozzano, Varese, Verona
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - 2. fázisTaking peopleA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- Where
- Catania, Florence, Milan, Orbassano, Rozzano, Udine
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06847867 · EU 2024-519928-24-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome, Turin
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleA Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
- Where
- Bologna, Cagliari, Florence, Genoa, Milan, Modena, Naples, Pavia
- Életkor
- 18 év to 64 év
- People
- 90 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT05693909 · EU 2023-507396-21-00 - 2. fázisTaking peopleEltrombopag for the treatment of thrombocytopenia due to low - and intermediate risk myelodysplastic syndromes.
- Where
- Bari, Firenze, Genova, Milano, Reggio Calabria, Roma, Rome, A.O.U Maggiore della Carità
- Életkor
- 18 év and over
- People
- 160
- Run by
- Associazione Qol-One
See details and how to joinNCT02912208 · EU 2024-520133-72-00 - 3. fázisTaking peopleFeasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
- Where
- Alexandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto, Catania, Cuneo, Ferrara, Foggia, Latina, Lecce, Mestre - Venezia, Milan, Modena, Monza, Naples, Palermo, Pescara, Piacenza, Pisa, Reggio Calabria, Reggio Emilia, Rimini, Roma, Rome, Salerno, Sassari, Siena, Tricase, Turin, Udine, Verona, Viterbo
- Életkor
- 18 év to 70 év
- People
- 274
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT04184505 · EU 2023-510515-19-00 - 2. fázisFut, nem toborozAnti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation
- Where
- Genoa, Rozzano
- Életkor
- 18 év to 99 év
- People
- 42
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT06892223 · EU 2024-516974-31-00